AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Masudur Rahman

Examiner Masudur Rahman appears to be about average relative to their peer examiners. Their lifetime grant ratio is 33.8%, they average 2.09 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant 2.09
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
5 years (2022-2026)
Phone
(571) 272-0196
Predicted Supervisor
James Douglas Schultz
Supervisor Phone
(571) 272-0763
Tech Center
1600 - Biotechnology and Organic
Group
1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated
139
Granted Applications
47
Non-Granted Applications
92
Avg OA / Grant
2.09
Last OA Observed
June 2026 (1 months ago)
Art Units Seen
1631 , 1633 , 1634
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 33.8% 2.09
Art Unit 31 38.1% 2.18
Group 245 37.7% 2.18
Tech Center 1,365 38.5% 2.02
USPTO 16,347 53.5% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2022; examiner may not yet have been active in the available dataset.
2022 2 1 50.0%
2023 21 8 38.1%
2024 33 24 72.7%
2025 50 14 28.0%
2026 33 0 0.0%

47 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 125 0.0% 7.2% 65.6% 10.4%
2 71 1.4% 8.5% 70.4% 8.5%
3 33 0.0% 3.0% 72.7% 18.2%
4 14 7.1% 7.1% 78.6% 7.1%
5 4 0.0% 0.0% 75.0% 25.0%
6 1 0.0% 0.0% 0.0% 100.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2022
1.6%
2023
0.0%
2024
1.4%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.